Pediatrix Medical Group (MD) Expected to Announce Quarterly Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.25 per share and revenue of $451.44 million for the quarter.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million. On average, analysts expect Pediatrix Medical Group to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Pediatrix Medical Group Stock Up 1.6 %

MD opened at $12.94 on Monday. The stock has a market cap of $1.11 billion, a price-to-earnings ratio of -10.78, a price-to-earnings-growth ratio of 1.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The firm’s fifty day moving average is $13.75 and its 200 day moving average is $14.00. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $17.67.

Wall Street Analyst Weigh In

Several brokerages have recently commented on MD. Truist Financial lowered their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research report on Friday, April 11th. UBS Group upped their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research note on Friday, February 21st. Finally, StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $16.75.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.